Plain-English translation of NCT07413640 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Microwave ablation is a minimally invasive procedure that uses heat to destroy liver tumors. This study is examining why the actual size of the treated area often differs from what doctors predict before the procedure, and what patient and tumor factors influence this difference.
Currently, doctors plan microwave ablation using standard manufacturer guidelines that don't account for individual differences in liver health, tumor location, or blood flow. This study aims to understand those real-world variations so doctors can better predict and plan treatment in the future.
You likely qualify if…
You likely don't qualify if…
If you join this study, you won't receive any new treatment — researchers will review your existing medical records and imaging scans from your microwave ablation procedure and follow-up visits over the next 6 to 12 weeks. The study team will compare the size of the treated area on scans taken immediately after your procedure and again at your follow-up appointments to understand what factors affected how much liver tissue was destroyed.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France
Sponsor
Central Hospital, Nancy, France
Enrollment target
~90 participants
Started
February 2026
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Valérie LAURENT, MD-PhD
Central Hospital, Nancy, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.